<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-TRED248T</identifier><date>2025</date><creator>Eberl, Andreja</creator><creator>Kadiš, Lea</creator><creator>Kerec Kos, Mojca</creator><relation>documents/doc/T/URN_NBN_SI_doc-TRED248T_001.pdf</relation><relation>documents/doc/T/URN_NBN_SI_doc-TRED248T_001.txt</relation><format format_type="issue">1</format><format format_type="volume">76</format><format format_type="type">article</format><format format_type="extent">str. 3-9</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">230892803</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-TRED248T</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">incidenca</subject><subject language_type_id="slv">infuzijska reakcija</subject><subject language_type_id="slv">neželeni učinki</subject><subject language_type_id="slv">parenteralna kemoterapija</subject><title>Infuzijske reakcije po parenteralni aplikaciji citostatikov na Onkološkem inštitutu Ljubljana med leti 2019-2023</title><title>Infusion reactions following parenteral administration of cytostatic drugs at the Institute of Oncology Ljubljana between 2019 and 2023</title></Record>